CCL22 and acute respiratory distress syndrome: Over the first 7 days of ARDS, patients on corticosteroids had lower overall levels of cytokines and chemokines (Supplemental Figure 8), with falling levels of CCL22 and the endothelial damage marker ANG2, and rising levels of sTNFR1 and MIP-1β.